Henry C Krutzsch

Title: Innovations of Henry C Krutzsch

Introduction

Henry C Krutzsch is a notable inventor based in Bethesda, MD (US). He has made significant contributions to the field of biotechnology, particularly in the development of peptides and their applications in cell behavior modulation. With a total of 18 patents, his work has had a profound impact on medical research and therapeutic applications.

Latest Patents

One of his latest patents focuses on peptides and their utility in modulating the behavior of cells expressing α3β1 integrins. This invention describes a peptide comprising a specific sequence that can inhibit cell adhesion, motility, and proliferation, while promoting other cellular processes. The patent also covers the development of peptide-substrate combinations suitable for cell growth, as well as applications in vascular grafts and artificial blood vessels. Additionally, it includes pharmaceutical compositions and methods for inhibiting angiogenesis using these peptides.

Career Highlights

Throughout his career, Henry C Krutzsch has worked with the United States of America as represented by the Department of Health and the National Institutes of Health, a component of the US Department of Health & Human Services. His work has been instrumental in advancing the understanding of peptide interactions and their potential therapeutic uses.

Collaborations

Henry has collaborated with notable colleagues such as David D Roberts and Lance A Liotta, contributing to a rich exchange of ideas and innovations in the field of biotechnology.

Conclusion

Henry C Krutzsch's innovative work in peptide research has led to numerous patents and significant advancements in medical science. His contributions continue to influence the development of new therapeutic strategies.